Delta3substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase ( PI3K) inhibitors

Details for Australian Patent Application No. 2012202457 (hide)

Owner Amgen Inc.

Inventors Chen, Yi; Cushing, Timothy D.; Hao, Xiaolin; Reichelt, Andreas; Rzasa, Robert M.; Seganish, Jennifer; Shin, Youngsook; Zhang, Dawei

Agent Shelston IP

Pub. Number AU-A-2012202457

Parent 2008231385

Filing date 27 April 2012

Wipo publication date 17 May 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202457

17 May 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202458-DNSSEC inline signing

2012202456-Temperature and moisture regulating topper for non-powered person-support surfaces